SlideShare a Scribd company logo
10 11
What was the study about?
From June 30, 2008, to March 30, 2009, 73 can-
cer patients participated in a five-week program
at the 3E-Centre in Germany. The 3E-Center is
neither a hospital, a clinic, nor a hotel. It is a
place where most terminal cancer patients can
learn the 3E-program of Lothar Hirneise, the
renowned German cancer advocate and sole
student of the famous Dr. Johanna Budwig, with
whom the “Flaxseed Lady” wrote two books and
presented several speeches together.
Six of these 73 patients came to the 3E-Centre
post-tumor surgery and had not procured further
conventional therapies before. At the time of
admission, all of the remaining 67 patients had
conventionally-diagnosed tumors. Nineteen
of these patients had inoperable tumors
while 16 patients had an R0-resection, but
with recurrences. Thirty-two, on the other
hand, had undergone surgery and had been
treated with chemotherapy and/or radiation
but experienced recurrences as well.
Two years later, 36 (53%) of the 67 patients, all
of whom had an average lifespan of six months,
were still living. Seven patients, with partly
multiple metastases, as well as one with inoper-
able glioblastoma were free of tumors. Fifteen
patients had a stable disease without further
tumor growth while the PETs of two patients
with a pancreatic carcinoma revealed normal
Standardized Uptake Values (SUVs). Although
the SUVs indicated no tumor-mass, the measure-
ments revealed a significant decrease in tumor
activity. Only three patients of the 36 reported
feeling worse at the end of the study than at
their discharge. Lastly, the six patients having
arrived free of tumors felt very well with no
relapses.
To the layman, these figures may sound unspec-
tacular, but when you go into detail, they are
extraordinary for various reasons.
1.
First of all, one out of every two patients was
still alive after two years despite being given an
average life expectancy of 6 months. The usual
excuse of conventional doctors such as “sponta-
neous remissions” or “rare miracle cures” do not
help here either as these are typically found only
in one patient of 100,000 and not at an incred-
ible 50%.
There is
always hope
by Marta Zaraskah
53%
SURVIVORS!
How many similar
studies do you know
with end-stage
cancer patients?
2010, a study was pub-
lished in Germany under
the inconspicuous
name: The 3E-program
in Combination with Papimi instead
of Palliative Intervention. Perhaps
it was the nomenclature or the
fact that this study never appeared
in any peer-reviewed journal,
that it never received the atten-
tion it deserved. In any case, I am
unaware of any other study with
such good results. Hence, I took the
time to take a closer look at the
3E-program.
The 3E-Program -
probably the world’s
most succesful
cancer therapy for
end-stage cancer
patients.
In
12 13
Dr. Johanna Budwig and Lothar Hirneise
The 3E program
is based on the
analysis of case
histories of thou-
sands of people
who have survived
late stage cancer.
3E-CENTER
GERMANY
LEARNING
FROM
PEOPLE
WHO
SURVIVED
CANCER
2.
Eight patients who had multiple metastases or
an inoperable brain tumor just two years ear-
lier were completely tumor-free by the end of
the study. These results are extremely unusual
because the patients were considered tradition-
ally incurable. Even if only these eight patients
survived, the study would still have been a great
success. It should be noted that if these patients
had been treated conventionally
with more chemotherapy and irradiation, 100%
would have died.
3.
Fifteen patients had a stable disease which
means these patients have already lived three
times longer than their doctors previously pre-
dicted. Additionally, these fifteen experienced a
cessation in tumor growth.
4.
Two patients with pancreat-
ic cancer were free of active
tumors indicated by their PETs
but were still visible in their
CTs. At that time, the radiolo-
gist in charge wrote in his
report that he had never seen
anything like this before and
recommended the patient to
continue with their therapy, no
matter what it was. It should
also be noted that the survival
rate of patients with pancreatic
cancer after two years is usu-
ally at 1-2%. Those aware of
this survival rate are better at
estimating these cases.
If any drug can produce even
roughlysimilar (healing) results,
the pharmaceutical company in
possession of said drug can
potentially earn billions. And
yet, the 3E-program is rela-
tively unknown. Unfortunately,
we’re still a long way from
seeing doctors and researchers
who move outside the main-
stream receive the attention
they deserve despite living in
the 21st century. Furthermore,
the official news on TV and
print media still rely heavi-
ly on arbitrary sponsors and
donors such as politicians, their
political parties, and members.
Social networks are no help
as well; filled to the brim with
millions of so-called experts
that make it nigh-impossible
for the real experts to separate
the wheat from the chaff.
It is not really surprising then
that the 3E-program remains
obscure, if not ridiculed or
discredited as pseudoscience
despite its proven successes.
Instead, millions of cancer
patients are persuaded to take
palliative therapies, such as
chemotherapy, every year.
Interestingly, doctors often
seemingly forget to inform
cancer patients, especial-
ly later stages, that pallia-
tive therapies are meant to
bring relief until the end of
life but not cure. This appar-
ent omission would then lead
patients to misunderstand the
treatment to be curative and
believe that at some point they
will become healthy again. In
reality, the actual intent of pal-
liative care is pain relief
without addressing
the cause of the
condition.
Consequently, the therapy or
treatment is procured because
no other option is available or
presented to the patient. Worse
yet, the patient is kept in the
dark if it means the physician
will earn money from the treat-
ment.
Faith, knowledge, or logic?
Many patients believe they
have no choice but to trust
their doctor, at times blindly,
because of the extensive expe-
rience and knowledge physi-
cians have acquired through
much study and training. In
addition, doctors own a veri-
table 007 license to kill or in
other words,“if a cancer patient
dies, the doctor or the therapy
is never guilty or at fault” and
that “the cancer just proved to
be stronger.”
14 15
THE 3E-CENTRE IS ONE OF THE TOP
13 ALTERNATIVE CANCER CLINICS IN GERMANY!
Holistic dentistry can
be very important
The highly effective ORIGINAL Oil-Protein Diet, created by the dis-
tinguished scientist Dr. Johanna Budwig, stands alongside other
effective therapies, to form the heart of the 3E-Program.
This shared madness, affectionately called folie à
deux by the French, has meanwhile reached such
proportions that the chemotherapeutic agent
gemcitabine, for instance, is still used on pancre-
atic cancer – a therapy that fails in about 96% of
patients. However, since other chemotherapies
are even worse, many acquiesce to the use of
gemcitabine.
Instead of considering different therapy
options, however, the dogma maintains that
chemotherapy is the best cancer therapy despite
now being almost completely unsuccessful at
certain stages or against certain types of cancer,
including pancreatic cancer. Still, many believe
that it is better to publish the success of che-
motherapy in medical journals and yellow press
magazines even with the many studies available
that point to the ineffectiveness of these thera-
pies in the treatment of tumors such as epithe-
lial tumors –which make up 90% of all tumors.
This insidious method and effective tactic is
a key reason why most patients, and even some
doctors, are unable to analyze and understand
all the facts correctly. What’s more, people who
hear completely different opinions are inclined
to follow the mainstream which in our case is
university medicine.
But what does this mean for a cancer patient?
Where, if not from the doctor or from the com-
mon media, should patients receive the nec-
essary information? Who else can they trust?
Unfortunately, this is not a simple question to
answer.We should, perhaps, flip the question and
instead ask: “Who can’t you trust?”
Bear in mind that some procedures may sound
appealing at first, but upon closer inspection,
isn’t always the case. Many NGO organizations
proclaim effective alternative cancer therapies
and that they are independent. Unfortunately,
however, these organizations are no better than
conventional studies at providing sound proof
on the efficacy of chemotherapy. Ultimately, can-
cer patients are, logically, only interested in one
question:
Will this treatment help me improve as
opposed to doing nothing?
It may be hard to believe, but it’s this very ques-
tion that’s never addressed nor answered in all
the thousands of studies available. Why not?
Let me explain. Studies typically involve two
groups. The first group will receive a specific
therapy while the second group will not. For
you to know if a particular treatment will help
you, there must be a clear difference between
the two groups at the aftermath of the study:
the group that received treatment must indi-
cate a clear improvement in
health and overall quality of
life. However, the placebo stud-
ies, normally present in other
faculties of medicine, do not
exist in oncology. Universities
and pharma companies try to
ascribe the lack of such stud-
ies to ethical reasons, that it is
impossible to give one group
chemotherapy while another
group receives a placebo or an
alternative therapy.
Think about it: these orga-
nizations have established a
system where they deem ethi-
cal the use of the terrible poi-
son derived from mustard gas
(cyclophosphamide) for treat-
ment but not, for instance,
High-Dose Intravenous Vitamin
C (IVC) therapy with similar
cytostatic functions while being
nearly free of side effects. Thus,
is the crazy medical world that
is oncology. Consequently, the
main question cancer patients
have has never been answered
until today, that is, by the titular
study in oncology.
Coincidentally, alternative
therapies also suffer from a
lack of double-blind studies
due to lack of funding or sup-
port from universities. In the
current state, the only question
that conventional doctors can
answer is whether one type of
chemotherapy is better than
another. Meanwhile, alternative
doctors can only explain why a
patient should pursue a particu-
lar therapy and how said thera-
py works. I was quite frustrated
when this problem dawned on
me. Nevertheless, this realiza-
tion helped me understand the
sad reality present in oncology
more clearly and also enabled
me to judge better the appro-
priate therapy one should pro-
cure. The following tips I’ll be
sharing will help you find the
best therapy for your condition.
First of all,you’ll need to decide
whether to follow a conven-
tional route or an alternative
one.
I know that being told “one can
have the best of both worlds”
sounds veryappealing to cancer
patients.However,this is a com-
mon misconception. Pursuing
both therapy groups is similar
16 17
Incidentally, if you believe that
tumor cells are not inherently
evil but rather a part of you
– the outcome of the life you
have led – then you should
opt for one or more alternative
therapies that may or may not
require surgery.
Due to the scarce num-
ber of helpful studies available,
one is left with their critically
and logically thinking mind.
For instance, I, personally, never
doubted conventional medi-
cine, that is until I heard a
lecture that raised the issue
in making a person extremely
ill with toxins so that they can
become healthy. This thought
was incredibly logical to me
that it changed my medical
thinking completely. Looking
now at the 3E-program by
Lothar Hirneise, logically, the
results of their study are no
longer surprising. I’ll describe
the principles mentioned in the
3E study below.
1. Always a curative approach
The3E-programis,firstandfore-
most, a fundamentally curative
approach. Both the therapist
and the patient should believe
that the applied is not palliative.
Additionally, life-prolonging
treatments should not be used.
I can agree with this approach
especially so since modern pla-
cebo research proves its valid-
ity today and so I’m entirely
compliant. Furthermore, this
particular view effectively rais-
es the question: “Why are end-
stage therapies that eventually
lead to loss of life still created/
favored?” It’s about time we
rethink the entire palliative
approach in oncology.
2. Detoxification over
poisoning
I can personally confirm that
the 3E-program follows this
particular approach absolutely.
It’s quite incredible that can-
cer patients today are poisoned
with all kinds of drugs but
detoxification therapies are
utterly absent or never pre-
scribed. Incidentally, this unfor-
tunate situation is not limited
to chemotherapy but nearly all
other prescription drugs.
3. Nutritional therapy is the
basis of the treatment
The 3E-program includes the
Original Oil-Protein Diet of Dr.
Johanna Budwig as its basic
nutritional therapy. In his writ-
ings and lectures, however,
Lothar Hirneise repeatedly
emphasizes that a raw food or
the Gerson Diet will also be
suitable. The disbelief exhib-
ited by oncologists in the sig-
nificance of nutritional thera-
pies has always shocked me.
Nonetheless, I do agree with
the approach that all cancer
therapies should include some
form of nutritional therapy.
to driving a car by simultaneously accelerating and braking: you’ll get nowhere, and you might even
damage the engine. Also, try to avoid the popular thinking that “If trying conventional medicine
doesn’t work, I can just pursue alternative medicine.”Take note that if you try one therapy group first
– say conventional treatment with their chemotherapy, radiation, and possibly surgery– you will not
be the same person post-treatment and the alternative therapy that may have helped you initially
no longer has the same appeal.
Secondly, you have a powerful
weapon at your disposal: logic.
Use it!
If you firmly believe a tumor
to be bad and you need to
kill or sever the evil then, by
all means, have an operation.
Eventually, you’ll also have to
undergo chemotherapy and
radiation. Before chemo, you’ll
have to submit to a chemo-
sensitivity test. Such a test will
partly determine the chemo-
therapy program that suits your
condition best and those that
are unsuitable. This informa-
tion, by itself, will be invaluable.
However, remember that radia-
tion therapy will not leave you
unscathed as some may think.
To be sure, damage to the body
should be expected. Hence, take
particular care if you plan to
follow a radiation therapy with
doses above 50 gray (Gy) as it
takes just 0.5 Gy to induce the
production of new cancer cells.
If a tumor has been completely
removed from healthy tissue
(R0 operation), then the ques-
tion on what is to be irradiated
should be asked. In most cases,
the argument is raised on the
issue of micrometastases – the
possibility that the cancer has
spread in minuscule amounts
to other tissue. Unfortunately,
the observation of microme-
tastases under a microscope
has not been accomplished
until today. The notion is quite
questionable since it only pre-
vails today due to an unproven
theory on creating irradiation
therapy which ultimately has
been proven to be carcinogenic.
18
4. Energetic programs and life changes
If you believe random DNA alternations are
responsible for cancer, then by all means,
continue following the lifestyle you’ve led up
to your diagnosis. On the other hand, if you
believe as I do, that influencing genes is pos-
sible and that there are physical and psycho-
logical reasons for cancer, then you’ll under-
stand the significance of life changes post-
diagnosis. In this method lies the strength of
the 3E-program bolstered by the consistent
implementation of the Oil-Protein Diet.
Lothar Hirneise and Klaus Pertl, the found-
ers of the 3E-Centre, repeatedly stress in their
writings and lectures the utmost importance
of finding the Whys behind cancer. According
to Hirneise and Pertl, this search must come
first while the eradication of a tumor, only
second.
5. Discipline is necessary
With all the strict routines and schedules,
major dietary adjustments, daily detoxi-
fication therapies; as well as an honest
self-examination of one’s life to necessitate
changes, one thing is certain: self-discipline
is an absolute necessity. Undoubtedly, the dis-
cipline we speak of will take years of practice
and, interestingly, may prove even more diffi-
cult for the patient than chemotherapy. In my
personal experience with cancer patients, one
also needs strict discipline. Sadly, not many
cancer patients have the luxury of time to
undergo therapy for months or years.
Why is the 3E-program so successful with
end-stage patients?
I believe that the key to the 3E-Program if
there is one at all, is this: the combination
of the search for the Whys – the reasons and
causes - behind the disease takes the high-
est priority while tumor eradication is kept in
second place and that it is the only place in
the world where the Original Budwig Protocol
is consistently performed. While many claim
to teach the Budwig Protocol, it is celebrated
in detail at the 3E Center.
Conversely, all conventional treatments
and most alternative therapies focus entirely
on the tumor and its eradication. However,
nearly all of these therapies are at a disad-
vantage since their main goal is the treat-
ment of a symptom – the tumor – but not the
underlying disease.
Metastases and second or even third
tumors have developed resistance to conven-
tional and alternative cell-destroying thera-
pies. When addressing end-stage cancer, only
a deep understanding of the Whys, coupled
with a focus on a healthy body (detoxifica-
tion, Oil-Protein Diet ...) and a sound mind,
(meditation, anti-stress training, visualization,
3E - goal setting program, synergetik, psycho-
bionik, ...) can lead to healthier future.
I hope that other clinics and doctors will
be able to understand and appreciate the
findings of the 3E-Program and in the future
achieve similar successes with end-stage
cancer patients similar to the findings at the
3E-Centre in Germany.
More informations: www.3e-centre.com * www.hirneise.com
www.3e-program.com * www.oilproteindiet.com * www.iopdf.com

More Related Content

What's hot

A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
Melanoma Research Foundation
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletterMaggie Pajak
 
Clinical trials 101
Clinical trials 101Clinical trials 101
Clinical trials 101
Melanoma Research Foundation
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Mina Max
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
Nilesh Kucha
 
What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?
Dana-Farber Cancer Institute
 
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMAEXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
Kanhu Charan
 
Dabrafenib Journal Club
Dabrafenib Journal Club Dabrafenib Journal Club
Dabrafenib Journal Club
kkorn22
 
Personalized medicine in pediatric cancer
Personalized medicine in pediatric cancerPersonalized medicine in pediatric cancer
Personalized medicine in pediatric cancer
Amir Abbas Hedayati Asl
 
Personalized Therapies for OA: Can Biomarkers Get Us There?
Personalized Therapies for OA: Can Biomarkers Get Us There?Personalized Therapies for OA: Can Biomarkers Get Us There?
Personalized Therapies for OA: Can Biomarkers Get Us There?
OARSI
 
2015 06-02 Steering group 'Personalized Medicine: eligible or not'
2015 06-02 Steering group 'Personalized Medicine: eligible or not'2015 06-02 Steering group 'Personalized Medicine: eligible or not'
2015 06-02 Steering group 'Personalized Medicine: eligible or not'
Alain van Gool
 
Solutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochureSolutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochure
Affymetrix
 
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
CrimsonpublishersCancer
 
How Maintenance Therapy Is Used in Lymphoma
How Maintenance Therapy Is Used in LymphomaHow Maintenance Therapy Is Used in Lymphoma
How Maintenance Therapy Is Used in Lymphoma
Dana-Farber Cancer Institute
 
Immunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast CancerImmunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast Cancer
bkling
 
Screening tests
Screening  testsScreening  tests
Screening tests
monaaboserea
 
Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)
Research On Global Markets
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast Cancer
Dana-Farber Cancer Institute
 
Medication saftey oncology setting
Medication saftey oncology settingMedication saftey oncology setting
Medication saftey oncology setting
مركز البحوث الأقسام العلمية
 

What's hot (20)

A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
A Paradigm Shift: Immunotherapy for Metastatic Melanoma – Michael K. Wong, MD...
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletter
 
Bridging the Divide
Bridging the DivideBridging the Divide
Bridging the Divide
 
Clinical trials 101
Clinical trials 101Clinical trials 101
Clinical trials 101
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
 
What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?
 
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMAEXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
EXTENDED TEMOZOLOMIDE IN GLIOBLASTOMA
 
Dabrafenib Journal Club
Dabrafenib Journal Club Dabrafenib Journal Club
Dabrafenib Journal Club
 
Personalized medicine in pediatric cancer
Personalized medicine in pediatric cancerPersonalized medicine in pediatric cancer
Personalized medicine in pediatric cancer
 
Personalized Therapies for OA: Can Biomarkers Get Us There?
Personalized Therapies for OA: Can Biomarkers Get Us There?Personalized Therapies for OA: Can Biomarkers Get Us There?
Personalized Therapies for OA: Can Biomarkers Get Us There?
 
2015 06-02 Steering group 'Personalized Medicine: eligible or not'
2015 06-02 Steering group 'Personalized Medicine: eligible or not'2015 06-02 Steering group 'Personalized Medicine: eligible or not'
2015 06-02 Steering group 'Personalized Medicine: eligible or not'
 
Solutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochureSolutions for Personalized Medicine brochure
Solutions for Personalized Medicine brochure
 
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
Bridging the Gap in Personalized Oncology using Omics Data and Epidemiology_C...
 
How Maintenance Therapy Is Used in Lymphoma
How Maintenance Therapy Is Used in LymphomaHow Maintenance Therapy Is Used in Lymphoma
How Maintenance Therapy Is Used in Lymphoma
 
Immunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast CancerImmunotherapy for Metastatic Triple Negative Breast Cancer
Immunotherapy for Metastatic Triple Negative Breast Cancer
 
Screening tests
Screening  testsScreening  tests
Screening tests
 
Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)Global precision medicine market (2018-2023)
Global precision medicine market (2018-2023)
 
Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast Cancer
 
Medication saftey oncology setting
Medication saftey oncology settingMedication saftey oncology setting
Medication saftey oncology setting
 

Similar to 3 e artikel-eng

Clinical trials article
Clinical trials articleClinical trials article
13 steps to aid recovery from cancer
13 steps to aid recovery from cancer13 steps to aid recovery from cancer
13 steps to aid recovery from cancer
Tommy Roche
 
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?Teresa Muñoz Migueláñez
 
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Ruchi Vahi
 
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Dana-Farber Cancer Institute
 
Personalized Cancer Care
Personalized Cancer CarePersonalized Cancer Care
Personalized Cancer Care
Paige W
 
How to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancyHow to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancy
Rajesh Gajbhiye
 
Mesotheliomahelp org treatment_clinical-trials
Mesotheliomahelp org treatment_clinical-trialsMesotheliomahelp org treatment_clinical-trials
Mesotheliomahelp org treatment_clinical-trials
Mesothelioma Help Cancer Organization
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
cowinhelen
 
Treating Cancer
Treating CancerTreating Cancer
Treating Cancer
a.crandon
 
Risk Communication and Medical Decision Making
Risk Communication  and Medical Decision MakingRisk Communication  and Medical Decision Making
Risk Communication and Medical Decision Making
Informed Medical Decisions Foundation
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee PublicationDenise Lee
 
Full Public Health Program Proposal: Paper
Full Public Health Program Proposal: PaperFull Public Health Program Proposal: Paper
Full Public Health Program Proposal: PaperChristina Spry
 
Mesotheliomahelp org treatment_faqs
Mesotheliomahelp org treatment_faqsMesotheliomahelp org treatment_faqs
Mesotheliomahelp org treatment_faqs
Mesothelioma Help Cancer Organization
 
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
Mesothelioma Help Cancer Organization
 
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
Mesothelioma Help Cancer Organization
 
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7wMesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
Mesothelioma Help Cancer Organization
 
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docxCopyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
bobbywlane695641
 

Similar to 3 e artikel-eng (20)

Clinical trials article
Clinical trials articleClinical trials article
Clinical trials article
 
13 steps to aid recovery from cancer
13 steps to aid recovery from cancer13 steps to aid recovery from cancer
13 steps to aid recovery from cancer
 
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?
Providing Hope in Terminal Cancer: When is it Appropriate and When is it Not?
 
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
 
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
Moving Beyond Resistance: Current Research in ER+ Metastatic Breast Cancer
 
Personalized Cancer Care
Personalized Cancer CarePersonalized Cancer Care
Personalized Cancer Care
 
How to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancyHow to have quality of life in Advanced ovarian malignancy
How to have quality of life in Advanced ovarian malignancy
 
Mesotheliomahelp org treatment_clinical-trials
Mesotheliomahelp org treatment_clinical-trialsMesotheliomahelp org treatment_clinical-trials
Mesotheliomahelp org treatment_clinical-trials
 
Nejm199504063321410
Nejm199504063321410Nejm199504063321410
Nejm199504063321410
 
Herceptin
HerceptinHerceptin
Herceptin
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
 
Treating Cancer
Treating CancerTreating Cancer
Treating Cancer
 
Risk Communication and Medical Decision Making
Risk Communication  and Medical Decision MakingRisk Communication  and Medical Decision Making
Risk Communication and Medical Decision Making
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee Publication
 
Full Public Health Program Proposal: Paper
Full Public Health Program Proposal: PaperFull Public Health Program Proposal: Paper
Full Public Health Program Proposal: Paper
 
Mesotheliomahelp org treatment_faqs
Mesotheliomahelp org treatment_faqsMesotheliomahelp org treatment_faqs
Mesotheliomahelp org treatment_faqs
 
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
Mesotheliomahelp org treatment_faqs__wvideo=ssqfsbmb2
 
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
Mesotheliomahelp org treatment_faqs__wvideo=5a09ejac9
 
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7wMesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
Mesotheliomahelp org treatment_faqs__wvideo=r9br3sh7w
 
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docxCopyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
Copyright B 2016 Wolters Kluwer Health, Inc. All rights reserv.docx
 

Recently uploaded

Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Lviv Startup Club
 
Buy Verified PayPal Account | Buy Google 5 Star Reviews
Buy Verified PayPal Account | Buy Google 5 Star ReviewsBuy Verified PayPal Account | Buy Google 5 Star Reviews
Buy Verified PayPal Account | Buy Google 5 Star Reviews
usawebmarket
 
Filing Your Delaware Franchise Tax A Detailed Guide
Filing Your Delaware Franchise Tax A Detailed GuideFiling Your Delaware Franchise Tax A Detailed Guide
Filing Your Delaware Franchise Tax A Detailed Guide
YourLegal Accounting
 
BeMetals Presentation_May_22_2024 .pdf
BeMetals Presentation_May_22_2024   .pdfBeMetals Presentation_May_22_2024   .pdf
BeMetals Presentation_May_22_2024 .pdf
DerekIwanaka1
 
Role of Remote Sensing and Monitoring in Mining
Role of Remote Sensing and Monitoring in MiningRole of Remote Sensing and Monitoring in Mining
Role of Remote Sensing and Monitoring in Mining
Naaraayani Minerals Pvt.Ltd
 
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-indiafalcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
Falcon Invoice Discounting
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
Nicola Wreford-Howard
 
April 2024 Nostalgia Products Newsletter
April 2024 Nostalgia Products NewsletterApril 2024 Nostalgia Products Newsletter
April 2024 Nostalgia Products Newsletter
NathanBaughman3
 
20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf
tjcomstrang
 
Memorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.pptMemorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.ppt
seri bangash
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
seoforlegalpillers
 
Enterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdfEnterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdf
KaiNexus
 
The Parable of the Pipeline a book every new businessman or business student ...
The Parable of the Pipeline a book every new businessman or business student ...The Parable of the Pipeline a book every new businessman or business student ...
The Parable of the Pipeline a book every new businessman or business student ...
awaisafdar
 
Project File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdfProject File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdf
RajPriye
 
Brand Analysis for an artist named Struan
Brand Analysis for an artist named StruanBrand Analysis for an artist named Struan
Brand Analysis for an artist named Struan
sarahvanessa51503
 
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
PaulBryant58
 
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
BBPMedia1
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
zoyaansari11365
 
Improving profitability for small business
Improving profitability for small businessImproving profitability for small business
Improving profitability for small business
Ben Wann
 
PriyoShop Celebration Pohela Falgun Mar 20, 2024
PriyoShop Celebration Pohela Falgun Mar 20, 2024PriyoShop Celebration Pohela Falgun Mar 20, 2024
PriyoShop Celebration Pohela Falgun Mar 20, 2024
PriyoShop.com LTD
 

Recently uploaded (20)

Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
 
Buy Verified PayPal Account | Buy Google 5 Star Reviews
Buy Verified PayPal Account | Buy Google 5 Star ReviewsBuy Verified PayPal Account | Buy Google 5 Star Reviews
Buy Verified PayPal Account | Buy Google 5 Star Reviews
 
Filing Your Delaware Franchise Tax A Detailed Guide
Filing Your Delaware Franchise Tax A Detailed GuideFiling Your Delaware Franchise Tax A Detailed Guide
Filing Your Delaware Franchise Tax A Detailed Guide
 
BeMetals Presentation_May_22_2024 .pdf
BeMetals Presentation_May_22_2024   .pdfBeMetals Presentation_May_22_2024   .pdf
BeMetals Presentation_May_22_2024 .pdf
 
Role of Remote Sensing and Monitoring in Mining
Role of Remote Sensing and Monitoring in MiningRole of Remote Sensing and Monitoring in Mining
Role of Remote Sensing and Monitoring in Mining
 
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-indiafalcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
 
April 2024 Nostalgia Products Newsletter
April 2024 Nostalgia Products NewsletterApril 2024 Nostalgia Products Newsletter
April 2024 Nostalgia Products Newsletter
 
20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf20240425_ TJ Communications Credentials_compressed.pdf
20240425_ TJ Communications Credentials_compressed.pdf
 
Memorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.pptMemorandum Of Association Constitution of Company.ppt
Memorandum Of Association Constitution of Company.ppt
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
 
Enterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdfEnterprise Excellence is Inclusive Excellence.pdf
Enterprise Excellence is Inclusive Excellence.pdf
 
The Parable of the Pipeline a book every new businessman or business student ...
The Parable of the Pipeline a book every new businessman or business student ...The Parable of the Pipeline a book every new businessman or business student ...
The Parable of the Pipeline a book every new businessman or business student ...
 
Project File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdfProject File Report BBA 6th semester.pdf
Project File Report BBA 6th semester.pdf
 
Brand Analysis for an artist named Struan
Brand Analysis for an artist named StruanBrand Analysis for an artist named Struan
Brand Analysis for an artist named Struan
 
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
Accpac to QuickBooks Conversion Navigating the Transition with Online Account...
 
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
 
Improving profitability for small business
Improving profitability for small businessImproving profitability for small business
Improving profitability for small business
 
PriyoShop Celebration Pohela Falgun Mar 20, 2024
PriyoShop Celebration Pohela Falgun Mar 20, 2024PriyoShop Celebration Pohela Falgun Mar 20, 2024
PriyoShop Celebration Pohela Falgun Mar 20, 2024
 

3 e artikel-eng

  • 1. 10 11 What was the study about? From June 30, 2008, to March 30, 2009, 73 can- cer patients participated in a five-week program at the 3E-Centre in Germany. The 3E-Center is neither a hospital, a clinic, nor a hotel. It is a place where most terminal cancer patients can learn the 3E-program of Lothar Hirneise, the renowned German cancer advocate and sole student of the famous Dr. Johanna Budwig, with whom the “Flaxseed Lady” wrote two books and presented several speeches together. Six of these 73 patients came to the 3E-Centre post-tumor surgery and had not procured further conventional therapies before. At the time of admission, all of the remaining 67 patients had conventionally-diagnosed tumors. Nineteen of these patients had inoperable tumors while 16 patients had an R0-resection, but with recurrences. Thirty-two, on the other hand, had undergone surgery and had been treated with chemotherapy and/or radiation but experienced recurrences as well. Two years later, 36 (53%) of the 67 patients, all of whom had an average lifespan of six months, were still living. Seven patients, with partly multiple metastases, as well as one with inoper- able glioblastoma were free of tumors. Fifteen patients had a stable disease without further tumor growth while the PETs of two patients with a pancreatic carcinoma revealed normal Standardized Uptake Values (SUVs). Although the SUVs indicated no tumor-mass, the measure- ments revealed a significant decrease in tumor activity. Only three patients of the 36 reported feeling worse at the end of the study than at their discharge. Lastly, the six patients having arrived free of tumors felt very well with no relapses. To the layman, these figures may sound unspec- tacular, but when you go into detail, they are extraordinary for various reasons. 1. First of all, one out of every two patients was still alive after two years despite being given an average life expectancy of 6 months. The usual excuse of conventional doctors such as “sponta- neous remissions” or “rare miracle cures” do not help here either as these are typically found only in one patient of 100,000 and not at an incred- ible 50%. There is always hope by Marta Zaraskah 53% SURVIVORS! How many similar studies do you know with end-stage cancer patients? 2010, a study was pub- lished in Germany under the inconspicuous name: The 3E-program in Combination with Papimi instead of Palliative Intervention. Perhaps it was the nomenclature or the fact that this study never appeared in any peer-reviewed journal, that it never received the atten- tion it deserved. In any case, I am unaware of any other study with such good results. Hence, I took the time to take a closer look at the 3E-program. The 3E-Program - probably the world’s most succesful cancer therapy for end-stage cancer patients. In
  • 2. 12 13 Dr. Johanna Budwig and Lothar Hirneise The 3E program is based on the analysis of case histories of thou- sands of people who have survived late stage cancer. 3E-CENTER GERMANY LEARNING FROM PEOPLE WHO SURVIVED CANCER 2. Eight patients who had multiple metastases or an inoperable brain tumor just two years ear- lier were completely tumor-free by the end of the study. These results are extremely unusual because the patients were considered tradition- ally incurable. Even if only these eight patients survived, the study would still have been a great success. It should be noted that if these patients had been treated conventionally with more chemotherapy and irradiation, 100% would have died. 3. Fifteen patients had a stable disease which means these patients have already lived three times longer than their doctors previously pre- dicted. Additionally, these fifteen experienced a cessation in tumor growth. 4. Two patients with pancreat- ic cancer were free of active tumors indicated by their PETs but were still visible in their CTs. At that time, the radiolo- gist in charge wrote in his report that he had never seen anything like this before and recommended the patient to continue with their therapy, no matter what it was. It should also be noted that the survival rate of patients with pancreatic cancer after two years is usu- ally at 1-2%. Those aware of this survival rate are better at estimating these cases. If any drug can produce even roughlysimilar (healing) results, the pharmaceutical company in possession of said drug can potentially earn billions. And yet, the 3E-program is rela- tively unknown. Unfortunately, we’re still a long way from seeing doctors and researchers who move outside the main- stream receive the attention they deserve despite living in the 21st century. Furthermore, the official news on TV and print media still rely heavi- ly on arbitrary sponsors and donors such as politicians, their political parties, and members. Social networks are no help as well; filled to the brim with millions of so-called experts that make it nigh-impossible for the real experts to separate the wheat from the chaff. It is not really surprising then that the 3E-program remains obscure, if not ridiculed or discredited as pseudoscience despite its proven successes. Instead, millions of cancer patients are persuaded to take palliative therapies, such as chemotherapy, every year. Interestingly, doctors often seemingly forget to inform cancer patients, especial- ly later stages, that pallia- tive therapies are meant to bring relief until the end of life but not cure. This appar- ent omission would then lead patients to misunderstand the treatment to be curative and believe that at some point they will become healthy again. In reality, the actual intent of pal- liative care is pain relief without addressing the cause of the condition. Consequently, the therapy or treatment is procured because no other option is available or presented to the patient. Worse yet, the patient is kept in the dark if it means the physician will earn money from the treat- ment. Faith, knowledge, or logic? Many patients believe they have no choice but to trust their doctor, at times blindly, because of the extensive expe- rience and knowledge physi- cians have acquired through much study and training. In addition, doctors own a veri- table 007 license to kill or in other words,“if a cancer patient dies, the doctor or the therapy is never guilty or at fault” and that “the cancer just proved to be stronger.”
  • 3. 14 15 THE 3E-CENTRE IS ONE OF THE TOP 13 ALTERNATIVE CANCER CLINICS IN GERMANY! Holistic dentistry can be very important The highly effective ORIGINAL Oil-Protein Diet, created by the dis- tinguished scientist Dr. Johanna Budwig, stands alongside other effective therapies, to form the heart of the 3E-Program. This shared madness, affectionately called folie à deux by the French, has meanwhile reached such proportions that the chemotherapeutic agent gemcitabine, for instance, is still used on pancre- atic cancer – a therapy that fails in about 96% of patients. However, since other chemotherapies are even worse, many acquiesce to the use of gemcitabine. Instead of considering different therapy options, however, the dogma maintains that chemotherapy is the best cancer therapy despite now being almost completely unsuccessful at certain stages or against certain types of cancer, including pancreatic cancer. Still, many believe that it is better to publish the success of che- motherapy in medical journals and yellow press magazines even with the many studies available that point to the ineffectiveness of these thera- pies in the treatment of tumors such as epithe- lial tumors –which make up 90% of all tumors. This insidious method and effective tactic is a key reason why most patients, and even some doctors, are unable to analyze and understand all the facts correctly. What’s more, people who hear completely different opinions are inclined to follow the mainstream which in our case is university medicine. But what does this mean for a cancer patient? Where, if not from the doctor or from the com- mon media, should patients receive the nec- essary information? Who else can they trust? Unfortunately, this is not a simple question to answer.We should, perhaps, flip the question and instead ask: “Who can’t you trust?” Bear in mind that some procedures may sound appealing at first, but upon closer inspection, isn’t always the case. Many NGO organizations proclaim effective alternative cancer therapies and that they are independent. Unfortunately, however, these organizations are no better than conventional studies at providing sound proof on the efficacy of chemotherapy. Ultimately, can- cer patients are, logically, only interested in one question: Will this treatment help me improve as opposed to doing nothing? It may be hard to believe, but it’s this very ques- tion that’s never addressed nor answered in all the thousands of studies available. Why not? Let me explain. Studies typically involve two groups. The first group will receive a specific therapy while the second group will not. For you to know if a particular treatment will help you, there must be a clear difference between the two groups at the aftermath of the study: the group that received treatment must indi- cate a clear improvement in health and overall quality of life. However, the placebo stud- ies, normally present in other faculties of medicine, do not exist in oncology. Universities and pharma companies try to ascribe the lack of such stud- ies to ethical reasons, that it is impossible to give one group chemotherapy while another group receives a placebo or an alternative therapy. Think about it: these orga- nizations have established a system where they deem ethi- cal the use of the terrible poi- son derived from mustard gas (cyclophosphamide) for treat- ment but not, for instance, High-Dose Intravenous Vitamin C (IVC) therapy with similar cytostatic functions while being nearly free of side effects. Thus, is the crazy medical world that is oncology. Consequently, the main question cancer patients have has never been answered until today, that is, by the titular study in oncology. Coincidentally, alternative therapies also suffer from a lack of double-blind studies due to lack of funding or sup- port from universities. In the current state, the only question that conventional doctors can answer is whether one type of chemotherapy is better than another. Meanwhile, alternative doctors can only explain why a patient should pursue a particu- lar therapy and how said thera- py works. I was quite frustrated when this problem dawned on me. Nevertheless, this realiza- tion helped me understand the sad reality present in oncology more clearly and also enabled me to judge better the appro- priate therapy one should pro- cure. The following tips I’ll be sharing will help you find the best therapy for your condition. First of all,you’ll need to decide whether to follow a conven- tional route or an alternative one. I know that being told “one can have the best of both worlds” sounds veryappealing to cancer patients.However,this is a com- mon misconception. Pursuing both therapy groups is similar
  • 4. 16 17 Incidentally, if you believe that tumor cells are not inherently evil but rather a part of you – the outcome of the life you have led – then you should opt for one or more alternative therapies that may or may not require surgery. Due to the scarce num- ber of helpful studies available, one is left with their critically and logically thinking mind. For instance, I, personally, never doubted conventional medi- cine, that is until I heard a lecture that raised the issue in making a person extremely ill with toxins so that they can become healthy. This thought was incredibly logical to me that it changed my medical thinking completely. Looking now at the 3E-program by Lothar Hirneise, logically, the results of their study are no longer surprising. I’ll describe the principles mentioned in the 3E study below. 1. Always a curative approach The3E-programis,firstandfore- most, a fundamentally curative approach. Both the therapist and the patient should believe that the applied is not palliative. Additionally, life-prolonging treatments should not be used. I can agree with this approach especially so since modern pla- cebo research proves its valid- ity today and so I’m entirely compliant. Furthermore, this particular view effectively rais- es the question: “Why are end- stage therapies that eventually lead to loss of life still created/ favored?” It’s about time we rethink the entire palliative approach in oncology. 2. Detoxification over poisoning I can personally confirm that the 3E-program follows this particular approach absolutely. It’s quite incredible that can- cer patients today are poisoned with all kinds of drugs but detoxification therapies are utterly absent or never pre- scribed. Incidentally, this unfor- tunate situation is not limited to chemotherapy but nearly all other prescription drugs. 3. Nutritional therapy is the basis of the treatment The 3E-program includes the Original Oil-Protein Diet of Dr. Johanna Budwig as its basic nutritional therapy. In his writ- ings and lectures, however, Lothar Hirneise repeatedly emphasizes that a raw food or the Gerson Diet will also be suitable. The disbelief exhib- ited by oncologists in the sig- nificance of nutritional thera- pies has always shocked me. Nonetheless, I do agree with the approach that all cancer therapies should include some form of nutritional therapy. to driving a car by simultaneously accelerating and braking: you’ll get nowhere, and you might even damage the engine. Also, try to avoid the popular thinking that “If trying conventional medicine doesn’t work, I can just pursue alternative medicine.”Take note that if you try one therapy group first – say conventional treatment with their chemotherapy, radiation, and possibly surgery– you will not be the same person post-treatment and the alternative therapy that may have helped you initially no longer has the same appeal. Secondly, you have a powerful weapon at your disposal: logic. Use it! If you firmly believe a tumor to be bad and you need to kill or sever the evil then, by all means, have an operation. Eventually, you’ll also have to undergo chemotherapy and radiation. Before chemo, you’ll have to submit to a chemo- sensitivity test. Such a test will partly determine the chemo- therapy program that suits your condition best and those that are unsuitable. This informa- tion, by itself, will be invaluable. However, remember that radia- tion therapy will not leave you unscathed as some may think. To be sure, damage to the body should be expected. Hence, take particular care if you plan to follow a radiation therapy with doses above 50 gray (Gy) as it takes just 0.5 Gy to induce the production of new cancer cells. If a tumor has been completely removed from healthy tissue (R0 operation), then the ques- tion on what is to be irradiated should be asked. In most cases, the argument is raised on the issue of micrometastases – the possibility that the cancer has spread in minuscule amounts to other tissue. Unfortunately, the observation of microme- tastases under a microscope has not been accomplished until today. The notion is quite questionable since it only pre- vails today due to an unproven theory on creating irradiation therapy which ultimately has been proven to be carcinogenic.
  • 5. 18 4. Energetic programs and life changes If you believe random DNA alternations are responsible for cancer, then by all means, continue following the lifestyle you’ve led up to your diagnosis. On the other hand, if you believe as I do, that influencing genes is pos- sible and that there are physical and psycho- logical reasons for cancer, then you’ll under- stand the significance of life changes post- diagnosis. In this method lies the strength of the 3E-program bolstered by the consistent implementation of the Oil-Protein Diet. Lothar Hirneise and Klaus Pertl, the found- ers of the 3E-Centre, repeatedly stress in their writings and lectures the utmost importance of finding the Whys behind cancer. According to Hirneise and Pertl, this search must come first while the eradication of a tumor, only second. 5. Discipline is necessary With all the strict routines and schedules, major dietary adjustments, daily detoxi- fication therapies; as well as an honest self-examination of one’s life to necessitate changes, one thing is certain: self-discipline is an absolute necessity. Undoubtedly, the dis- cipline we speak of will take years of practice and, interestingly, may prove even more diffi- cult for the patient than chemotherapy. In my personal experience with cancer patients, one also needs strict discipline. Sadly, not many cancer patients have the luxury of time to undergo therapy for months or years. Why is the 3E-program so successful with end-stage patients? I believe that the key to the 3E-Program if there is one at all, is this: the combination of the search for the Whys – the reasons and causes - behind the disease takes the high- est priority while tumor eradication is kept in second place and that it is the only place in the world where the Original Budwig Protocol is consistently performed. While many claim to teach the Budwig Protocol, it is celebrated in detail at the 3E Center. Conversely, all conventional treatments and most alternative therapies focus entirely on the tumor and its eradication. However, nearly all of these therapies are at a disad- vantage since their main goal is the treat- ment of a symptom – the tumor – but not the underlying disease. Metastases and second or even third tumors have developed resistance to conven- tional and alternative cell-destroying thera- pies. When addressing end-stage cancer, only a deep understanding of the Whys, coupled with a focus on a healthy body (detoxifica- tion, Oil-Protein Diet ...) and a sound mind, (meditation, anti-stress training, visualization, 3E - goal setting program, synergetik, psycho- bionik, ...) can lead to healthier future. I hope that other clinics and doctors will be able to understand and appreciate the findings of the 3E-Program and in the future achieve similar successes with end-stage cancer patients similar to the findings at the 3E-Centre in Germany. More informations: www.3e-centre.com * www.hirneise.com www.3e-program.com * www.oilproteindiet.com * www.iopdf.com